viewesense-Lab Ltd

eSense-Lab in trading halt ahead of news on research agreement with Israeli Ministry of Health

eSense-Lab is progressing a commercialisation strategy for evidence-based terpene product development for medicinal and wellness uses.

esense-Lab Ltd - eSense-Lab in trading halt ahead of news on research agreement with Israeli Ministry of Health
The company is developing proprietary terpene mixes with anti-viral activity

eSense-Lab Ltd (ASX:ESE) has been granted a trading halt by the ASX pending an announcement regarding a research agreement with the Israeli Ministry of Health to test the company’s proprietary TRP-ENV and TRP-COV compounds for efficacy against human coronavirus.

The halt will remain in place until the start of normal trading on Monday, July 27, 2020, or when an announcement is released to the market, whichever occurs earliest.

Sanitisers infused with eSense’s unique terpenes

eSense recently entered into a joint venture with the owner of Wise Winery, a family-owned wine company based in Eagle Bay in the northern Margaret River Wine region.

Wise Winery had started producing surface and hand sanitiser products using ethanol distilled from its own Chardonnay wine at its Eagle Bay distillery.

Under the joint venture, Wise Winery will broaden its sanitiser product offering to include ethanol sanitisers infused with eSense’s unique terpenes.

The joint venture company will place the first order of 2 million terpenes units for infusion into the sanitiser products, which will generate about US$600,000 revenue for eSense.

Quick facts: esense-Lab Ltd

Price: 0.018 AUD

Market: ASX
Market Cap: $9.18 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of esense-Lab Ltd named herein, including the promotion by the Company of esense-Lab Ltd in any Content on the Site, the Company receives from...


Orthocell's Paul Anderson hails FDA approval for dental bone and tissue...

Orthocell Ltd's (ASX:OCC) Paul Anderson caught up with Proactive's Andrew Scott soon after announcing they've received Food and Drug Administration’s (FDA) 510(k) clearance to market and supply its CelGro collagen medical device for dental bone and tissue regeneration procedures in the US....

1 day, 16 hours ago

2 min read